Curative Biotechnology Inc. announced that Cary Sucoff has joined its Board of Directors as an independent director. With over 35 years of legal and securities industry experience, Cary Sucoff has participated in the financing of over one hundred public and private companies and is currently on the boards of, or an advisor to, six healthcare and biotechnology companies. Mr. Sucoff is an expert in legal, compliance, corporate strategy, and capital markets and has chaired or sat on audit, compensation, nominating/governance, and special committees.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0181 USD | +41.96% | -25.51% | -15.02% |
06/05 | Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
1st Jan change | Capi. | |
---|---|---|
-15.02% | 1.63Cr | |
+41.79% | 5.4TCr | |
-0.56% | 4.19TCr | |
+49.62% | 4.2TCr | |
-7.20% | 2.84TCr | |
+12.59% | 2.64TCr | |
-21.51% | 1.9TCr | |
+6.92% | 1.3TCr | |
+24.91% | 1.22TCr | |
+29.60% | 1.23TCr |
- Stock Market
- Equities
- CUBT Stock
- News Curative Biotechnology, Inc.
- Curative Biotechnology, Inc. Appoints Cary Sucoff to Board of Directors